Vertex Ignored Red Flags In Clinical Trial, 1st Circ. Told
By Brian Amaral ( July 26, 2016, 3:40 PM EDT) -- A union retirement fund told the First Circuit in Boston on Tuesday that it plausibly alleged in a putative securities fraud class action that Vertex and several of its corporate leaders who made millions on stock trades acted with at least recklessness when the results of a clinical drug trial — later shown to be overstated — were released....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.